[go: up one dir, main page]

CN102702183A - New synthesis process of 3-isopropyl-(1,2,4)oxadiazol-5-piperidine-1-carbonyl tertbutyl ester compounds - Google Patents

New synthesis process of 3-isopropyl-(1,2,4)oxadiazol-5-piperidine-1-carbonyl tertbutyl ester compounds Download PDF

Info

Publication number
CN102702183A
CN102702183A CN2012101533911A CN201210153391A CN102702183A CN 102702183 A CN102702183 A CN 102702183A CN 2012101533911 A CN2012101533911 A CN 2012101533911A CN 201210153391 A CN201210153391 A CN 201210153391A CN 102702183 A CN102702183 A CN 102702183A
Authority
CN
China
Prior art keywords
isopropyl
piperidine
acid
butyl ester
carbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012101533911A
Other languages
Chinese (zh)
Inventor
张福治
丁炬平
张仁延
余强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cgenetech Suzhou China Co Ltd
Original Assignee
Cgenetech Suzhou China Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cgenetech Suzhou China Co Ltd filed Critical Cgenetech Suzhou China Co Ltd
Priority to CN2012101533911A priority Critical patent/CN102702183A/en
Publication of CN102702183A publication Critical patent/CN102702183A/en
Pending legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a new synthesis process of 3-isopropyl-(1,2,4)oxadiazol-5-piperidine-1-carbonyl tertbutyl ester compounds, effectively solving the disadvantages of the previously reported process, such as troublesome aftertreatment, high cost and relatively low yield. The new two-step reaction synthesis process comprises the steps of reacting material cyano group with hydroxyamino, and directly reacting with acid through a one-pot method. The whole process is easy to operate, the aftertreatment is simple, and the yield is greatly improved.

Description

3-异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物的合成新工艺New Synthesis Process of 3-Isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl Ester

技术领域 technical field

本发明涉及3-异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物的合成新工艺,属医药,化工技术领域。 The invention relates to a new synthesis process of 3-isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl ester compounds, belonging to the technical fields of medicine and chemical industry.

背景技术 Background technique

异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物是重要的化学中间体,广泛用于医药及农药领域,目前见诸报道的合成路线大都是原料氰基先与羟氨反应,再与酸缩合后加热脱水得到目标产物,具体路线如下: Isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl ester compounds are important chemical intermediates, which are widely used in the fields of medicine and pesticides, and their synthetic routes are currently reported Mostly, the raw material cyano group first reacts with hydroxylamine, then condenses with acid and then heats and dehydrates to obtain the target product. The specific route is as follows:

Figure 189108DEST_PATH_IMAGE001
Figure 189108DEST_PATH_IMAGE001

上述路线需要先缩合反应成酰胺处理之后再脱水关环,存在后处理繁琐,成本高,收率偏低等不足。 The above-mentioned route needs to be condensed and reacted to form an amide first, and then dehydrated and ring-closed, which has the disadvantages of cumbersome post-treatment, high cost, and low yield.

发明内容 Contents of the invention

本发明针对3-异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物以往的合成方法后处理繁琐,成本高,收率偏低等不足,发明了所述的以原料氰基与羟氨反应后直接与酸一锅法完成两步反应,使整个过程易于操作,后处理简单,收率大大提高。 The present invention aims at the deficiencies of 3-isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl ester compound in the previous synthetic method, which are cumbersome post-treatment, high cost, low yield, etc. , invented the two-step reaction with raw material cyano group and hydroxylamine, and then directly reacted with acid in one pot, so that the whole process is easy to operate, the post-treatment is simple, and the yield is greatly improved.

 所述的3-异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物合成,原料氰基类包括但不仅限于乙腈,正丙睛,异丙晴,叔丁腈,异丁腈,正丁腈,正戊腈,异戊腈,正己腈等等。 The 3-isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl ester compound is synthesized, the raw material cyano group includes but not limited to acetonitrile, n-propionitrile, iso Acrylonitrile, tert-butyronitrile, isobutyronitrile, n-butyronitrile, n-valeronitrile, isovaleronitrile, n-capronitrile, etc.

所述的3-异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物合成,原料酸类包括但不仅限于4-羰基叔丁酯-1甲酸,乙酸,丙酸,环丙酸,正丁酸,环丁酸,环戊酸等。 The 3-isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl ester compound is synthesized, and the raw materials include but not limited to 4-carbonyl tert-butyl ester-1 Formic acid, acetic acid, propionic acid, cyclopropionic acid, n-butyric acid, cyclobutanoic acid, cyclopentanoic acid, etc.

所述3-异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物合成,由(2)和(3)一锅反应溶液包含但不仅限于甲苯,二甲苯,苯,二氧六环,1,2-二氯乙烷等。 The 3-isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl ester compound is synthesized from (2) and (3) one-pot reaction solutions including but not limited to Toluene, xylene, benzene, dioxane, 1,2-dichloroethane, etc.

所述3-异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物合成由(2)和(3)一锅反应温度包含但不仅限于0摄氏度到200摄氏度。 The 3-isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl ester compound is synthesized by (2) and (3) one-pot reaction temperature including but not limited to 0 Celsius to 200 Celsius.

所述3-异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物合成一锅法,中途不纯化,最后统一处理。 The 3-isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl ester compound is synthesized by a one-pot method, without purification in the middle, and finally unified treatment.

上述以氰基为起始原料的化学反应路线如下: The above-mentioned chemical reaction scheme with cyano group as starting material is as follows:

Figure 456141DEST_PATH_IMAGE002
Figure 456141DEST_PATH_IMAGE002

具体实施方式 Detailed ways

制备化合物(2): Preparation of compound (2):

起始原料(1)138克(2摩尔)溶解在1.4升无水甲醇,加入盐酸羟胺152克(2.2摩尔),在冰水冷却下分批加88克(2.2摩尔)氢氧化钠,加完后室温搅拌过夜,蒸去甲醇,残余液倒入1升冰水中,乙酸乙酯(500毫升*4)分层萃取,饱和盐水(500毫升)洗,无水硫酸钠干燥,过滤,旋干,得到白色固体173克(收率 85%)。 Dissolve 138 grams (2 moles) of starting material (1) in 1.4 liters of anhydrous methanol, add 152 grams (2.2 moles) of hydroxylamine hydrochloride, add 88 grams (2.2 moles) of sodium hydroxide in batches under ice-water cooling, and complete the addition After stirring overnight at room temperature, the methanol was distilled off, the residue was poured into 1 liter of ice water, extracted with ethyl acetate (500 ml*4), washed with saturated brine (500 ml), dried over anhydrous sodium sulfate, filtered, and spin-dried. 173 g (yield 85%) of white solid were obtained.

一锅法制备化合物(5): One-pot preparation of compound (5):

新制备的化合物(2)102克(1摩尔)溶解在1升甲苯溶液中,加入4-羰基叔丁酯-1-哌啶酸229克(1摩尔),加完后回流搅拌24小时,冷却加入催化量的对甲苯磺酸(1克)再回流反应24小时,旋干,乙酸乙酯重结晶,得到 236克目标产物(收率80%)。 102 grams (1 mole) of the newly prepared compound (2) was dissolved in 1 liter of toluene solution, and 229 grams (1 mole) of 4-carbonyl tert-butyl ester-1-piperidine acid was added, and after the addition was completed, reflux and stirred for 24 hours, and cooled A catalytic amount of p-toluenesulfonic acid (1 g) was added and refluxed for 24 hours, spin-dried, and recrystallized from ethyl acetate to obtain 236 g of the target product (yield 80%).

Claims (5)

1.所述的3-异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物合成,原料氰基类包括但不仅限于乙腈,正丙睛,异丙晴,叔丁腈,异丁腈,正丁腈,正戊腈,异戊腈,正己腈等等。 1. The synthesis of the 3-isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl ester compound, the raw material cyano group includes but not limited to acetonitrile, n-propionitrile , Isopropyl nitrile, tert-butyronitrile, isobutyronitrile, n-butyronitrile, n-valeronitrile, isovaleronitrile, n-capronitrile and so on. 2.所述的3-异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物合成,原料酸类包括但不仅限于4-羰基叔丁酯-1甲酸,乙酸,丙酸,环丙酸,正丁酸,环丁酸,环戊酸等。 2. Synthesis of the 3-isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl ester compound, the raw acid includes but not limited to 4-carbonyl tert-butyl ester -1 Formic acid, acetic acid, propionic acid, cyclopropionic acid, n-butyric acid, cyclobutanoic acid, cyclopentanoic acid, etc. 3.所述3-异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物合成,由(2)和(3)一锅反应溶液包含但不仅限于甲苯,二甲苯,苯,二氧六环,1,2-二氯乙烷等。 3. The 3-isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl ester compound is synthesized by (2) and (3) one-pot reaction solution containing but Not limited to toluene, xylene, benzene, dioxane, 1,2-dichloroethane, etc. 4.所述3-异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物合成由(2)和(3)一锅反应温度包含但不仅限于0摄氏度到200摄氏度。 4. The 3-isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl ester compound is synthesized by (2) and (3) one-pot reaction temperature including but not only Limited to 0°C to 200°C. 5.所述3-异丙基-(1,2,4)噁二唑-5-哌啶-1-羰基叔丁酯类化合物合成一锅法,中途不纯化,最后统一处理。 5. The 3-isopropyl-(1,2,4)oxadiazole-5-piperidine-1-carbonyl tert-butyl ester compound is synthesized by a one-pot method, without purification in the middle, and finally unified treatment.
CN2012101533911A 2012-05-17 2012-05-17 New synthesis process of 3-isopropyl-(1,2,4)oxadiazol-5-piperidine-1-carbonyl tertbutyl ester compounds Pending CN102702183A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101533911A CN102702183A (en) 2012-05-17 2012-05-17 New synthesis process of 3-isopropyl-(1,2,4)oxadiazol-5-piperidine-1-carbonyl tertbutyl ester compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101533911A CN102702183A (en) 2012-05-17 2012-05-17 New synthesis process of 3-isopropyl-(1,2,4)oxadiazol-5-piperidine-1-carbonyl tertbutyl ester compounds

Publications (1)

Publication Number Publication Date
CN102702183A true CN102702183A (en) 2012-10-03

Family

ID=46895286

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101533911A Pending CN102702183A (en) 2012-05-17 2012-05-17 New synthesis process of 3-isopropyl-(1,2,4)oxadiazol-5-piperidine-1-carbonyl tertbutyl ester compounds

Country Status (1)

Country Link
CN (1) CN102702183A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080188478A1 (en) * 2005-04-26 2008-08-07 Pfizer Inc. Compounds Useful In Therapy
CN102070513A (en) * 2011-01-20 2011-05-25 兰州博实生化科技有限责任公司 Synthesis method of 1-teriary butoxy carbonyl-4-piperidone
TW201202230A (en) * 2010-05-24 2012-01-16 Mitsubishi Tanabe Pharma Corp Novel quinazoline compound

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080188478A1 (en) * 2005-04-26 2008-08-07 Pfizer Inc. Compounds Useful In Therapy
TW201202230A (en) * 2010-05-24 2012-01-16 Mitsubishi Tanabe Pharma Corp Novel quinazoline compound
CN102070513A (en) * 2011-01-20 2011-05-25 兰州博实生化科技有限责任公司 Synthesis method of 1-teriary butoxy carbonyl-4-piperidone

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GRAEME SEMPLE,等: "Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119", 《J.MED.CHEM》 *

Similar Documents

Publication Publication Date Title
CN102344415B (en) The preparation method of Azilsartan intermediate
KR101472686B1 (en) Method for preparation of benzimidazole derivatives
CN102311355A (en) Preparation method of rofecoxib
CN102964313B (en) Synthetic method of febuxostat
CN102351800A (en) Method for preparing 5-methylbenzimidazole-2-methyl carbamate
CN102850325A (en) Preparation method of Dabigatran etexilate key intermediate
CN105218329B (en) Intermediate of liflozin analogues and preparation method of intermediate
CN103896809B (en) The synthetic method of the naphthols mesylate of the amidino groups of Nafamostat Mesilate intermediate -6 2
CN103664631B (en) Preparation method of naftifine hydrochloride
CN102898345B (en) A kind of preparation method of N-(2,4,6-trichlorophenyl) maleimide
CN102976998A (en) Method for synthesizing 3-(5-chloro-2-phenoxy-phenyl)-1-methyl-pyrrolidine-2, 4-diketone
CN106431969A (en) Method for preparing 2-methyl-4-formaldoxime methyl benzoate
CN101973960B (en) Improved method for preparing benzo[d][1,2,3] thiadiazole-7-formic acid trifluoroacetate
CN103923040B (en) A kind of method preparing furfural oxime acid
CN103450092B (en) Synthesis method of metronidazole-sulfanilamide derivatives
CN102702183A (en) New synthesis process of 3-isopropyl-(1,2,4)oxadiazol-5-piperidine-1-carbonyl tertbutyl ester compounds
CN103896933B (en) A kind of Rivaroxaban intermediate and preparation method thereof
CN105348101A (en) Preparation method of methyl p-chlorocinnamate
CN104496892A (en) Novel technology for synthesizing 4-dimethylamino-pyridine
CN105237379B (en) Production method for 4-bromo fluorenone
CN104327040A (en) Synthetic method for 2-thiopheneacetic acid
CN104311446A (en) Method for catalysis synthesis of (Z)-2-acetylamino methyl cinnamate through DCC/DMAP
CN109369494B (en) A kind of preparation method of N-phenylacetyl-L-proline
CN103570546B (en) A kind of Industrialized synthesis method of danshensu norbornene ester
CN102898373B (en) Preparation method of Z-3-acyloxy-3-(1-ethylpyrazolyl)acrylonitrile compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121003